SG152234A1 - Regiospecific synthesis of rapamycin 42-ester derivatives - Google Patents
Regiospecific synthesis of rapamycin 42-ester derivativesInfo
- Publication number
- SG152234A1 SG152234A1 SG200902515-6A SG2009025156A SG152234A1 SG 152234 A1 SG152234 A1 SG 152234A1 SG 2009025156 A SG2009025156 A SG 2009025156A SG 152234 A1 SG152234 A1 SG 152234A1
- Authority
- SG
- Singapore
- Prior art keywords
- rapamycin
- ester derivatives
- regiospecific synthesis
- ester
- regiospecific
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56192604P | 2004-04-14 | 2004-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG152234A1 true SG152234A1 (en) | 2009-05-29 |
Family
ID=34965235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200902515-6A SG152234A1 (en) | 2004-04-14 | 2005-04-12 | Regiospecific synthesis of rapamycin 42-ester derivatives |
Country Status (23)
Country | Link |
---|---|
US (1) | US7268144B2 (ja) |
EP (1) | EP1737869A1 (ja) |
JP (1) | JP4224115B2 (ja) |
KR (1) | KR20070015544A (ja) |
CN (1) | CN1942476A (ja) |
AR (1) | AR049019A1 (ja) |
AU (1) | AU2005238431A1 (ja) |
BR (1) | BRPI0509852A (ja) |
CA (1) | CA2562952A1 (ja) |
CL (1) | CL2008000507A1 (ja) |
CR (1) | CR8646A (ja) |
EC (1) | ECSP066927A (ja) |
GT (1) | GT200500085A (ja) |
IL (1) | IL178315A0 (ja) |
MX (1) | MXPA06011881A (ja) |
NO (1) | NO20065090L (ja) |
PA (1) | PA8629901A1 (ja) |
PE (1) | PE20060253A1 (ja) |
RU (1) | RU2387657C2 (ja) |
SG (1) | SG152234A1 (ja) |
TW (1) | TW200536542A (ja) |
UA (1) | UA87492C2 (ja) |
WO (1) | WO2005105811A1 (ja) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE385795T1 (de) | 2002-07-30 | 2008-03-15 | Wyeth Corp | Parenterale formulierungen mit einem rapamycin hydroxyester |
JP2007532655A (ja) * | 2004-04-14 | 2007-11-15 | ワイス | ラパマイシンコンジュゲートおよび抗体のための前駆体である、ジカルボン酸とのラパマイシン42−エステルおよびジカルボン酸とのfk−50632−エステルの調製プロセス |
EP1740710A1 (en) * | 2004-04-27 | 2007-01-10 | Wyeth | Labeling of rapamycin using rapamycin-specific methylases |
AU2005292647A1 (en) * | 2004-08-10 | 2006-04-13 | Wyeth | CCI-779 derivatives and methods of making same |
KR20070107030A (ko) * | 2005-02-09 | 2007-11-06 | 와이어쓰 | Cci-779 다형체 및 그의 용도 |
US7538119B2 (en) * | 2005-11-04 | 2009-05-26 | Wyeth | 41-Methoxy isotope labeled rapamycin 42-ester |
BRPI0619592A2 (pt) * | 2005-12-07 | 2016-09-06 | Wyeth Corp | métodos para medir a qualidade da partícula de um composto de rapamicina, para determinar o tamanho de partícula médio de uma amostra e a cristalinidade de um composto de rapamicina, e para a purificação de rapamicina |
TW200732342A (en) * | 2005-12-07 | 2007-09-01 | Wyeth Corp | Process for the preparation of purified crystalline CCI-779 |
CA2630645A1 (en) * | 2005-12-07 | 2007-06-14 | Wyeth | Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate |
BRPI0708562A2 (pt) * | 2006-03-07 | 2011-06-07 | Wyeth Corp | processos para preparar conjugados de polietileno glicor de macrolìdeos imunossupressores, um macrolìdeo imunossupressor peguilado, uma rapamicina peguilada, um everolimus peguilado, um cci-779 peguilado e um tacrolimus peguilado, e, produto |
US8430055B2 (en) | 2008-08-29 | 2013-04-30 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414909B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
TW200845960A (en) * | 2007-04-05 | 2008-12-01 | Wyeth Corp | Wortmannin-rapalog conjugate and uses thereof |
US20090253733A1 (en) * | 2008-04-02 | 2009-10-08 | Biointeractions, Ltd. | Rapamycin carbonate esters |
US20110098241A1 (en) * | 2008-04-14 | 2011-04-28 | Poniard Pharmaceuticals, Inc. | Rapamycin analogs as anti-cancer agents |
CN101676291B (zh) * | 2008-09-18 | 2012-05-09 | 上海海和药物研究开发有限公司 | 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途 |
US20120064143A1 (en) | 2008-11-11 | 2012-03-15 | The Board Of Regents Of The University Of Texas System | Inhibition of mammalian target of rapamycin |
IT1394309B1 (it) * | 2009-05-22 | 2012-06-06 | Poli Ind Chimica Spa | Nuovo approccio chimico-enzimatico alla sintesi del pimecrolimus |
US10391059B2 (en) | 2009-11-11 | 2019-08-27 | Rapamycin Holdings, Inc. | Oral rapamycin nanoparticle preparations and use |
US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
EP2694520A1 (en) * | 2011-04-01 | 2014-02-12 | Sandoz AG | Regioselective acylation of rapamycin at the c-42 position |
ES2574522T3 (es) * | 2012-06-08 | 2016-06-20 | Biotronik Ag | Ésteres 40-O-hidrocarburo cíclico de rapamicina, composiciones y procedimientos |
US10751450B2 (en) | 2012-06-08 | 2020-08-25 | Biotronik Ag | Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods |
US20160030401A1 (en) | 2013-03-13 | 2016-02-04 | The Board Of Regents Of The University Of Texas System | Use of mtor inhibitors for prevention of intestinal polyp growth and cancer |
SG11201507406YA (en) * | 2013-03-15 | 2015-10-29 | Biosensors Int Group Ltd | Purification of rapamycin derivatives |
US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
JP7185633B2 (ja) | 2017-02-17 | 2022-12-07 | トレベナ・インコーポレイテッド | 7員アザ複素環を含有するデルタ-オピオイド受容体調節化合物、その使用方法及び製造方法 |
ES2871499T3 (es) | 2017-05-15 | 2021-10-29 | Bard Inc C R | Dispositivo médico con recubrimiento de elución de fármaco y capa intermedia |
AU2018370237A1 (en) * | 2017-11-20 | 2020-06-04 | Icahn School Of Medicine At Mount Sinai | Inhibiting trained immunity with a therapeutic nanobilogic composition |
US11541152B2 (en) | 2018-11-14 | 2023-01-03 | Lutonix, Inc. | Medical device with drug-eluting coating on modified device surface |
US20220176084A1 (en) | 2019-04-08 | 2022-06-09 | Bard Peripheral Vascular, Inc. | Medical device with drug-eluting coating on modified device surface |
US20240100025A1 (en) * | 2020-12-14 | 2024-03-28 | Biotronik Ag | Materials and Methods for Treating Viral and Other Medical Conditions |
MX2023011004A (es) | 2021-03-19 | 2024-01-08 | Trained Therapeutix Discovery Inc | Compuestos para regular la inmunidad entrenada y métodos para usarlos. |
WO2023070605A1 (en) * | 2021-10-29 | 2023-05-04 | Trevena, Inc. | Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds |
CN118027062A (zh) * | 2023-11-03 | 2024-05-14 | 沈阳药科大学 | 一种雷帕霉素前药及其纳米制剂的制备和应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US4316885A (en) | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
US4650803A (en) | 1985-12-06 | 1987-03-17 | University Of Kansas | Prodrugs of rapamycin |
US5210030A (en) | 1990-06-25 | 1993-05-11 | Merck & Co., Inc. | Process for selectively acylating immunomycin |
PT98990A (pt) * | 1990-09-19 | 1992-08-31 | American Home Prod | Processo para a preparacao de esteres de acidos carboxilicos de rapamicina |
US5233036A (en) | 1990-10-16 | 1993-08-03 | American Home Products Corporation | Rapamycin alkoxyesters |
US5100883A (en) | 1991-04-08 | 1992-03-31 | American Home Products Corporation | Fluorinated esters of rapamycin |
US5118678A (en) | 1991-04-17 | 1992-06-02 | American Home Products Corporation | Carbamates of rapamycin |
US5118677A (en) | 1991-05-20 | 1992-06-02 | American Home Products Corporation | Amide esters of rapamycin |
US5260300A (en) | 1992-11-19 | 1993-11-09 | American Home Products Corporation | Rapamycin carbonate esters as immuno-suppressant agents |
US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US5780462A (en) | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
TWI256395B (en) | 1999-09-29 | 2006-06-11 | Wyeth Corp | Regioselective synthesis of rapamycin derivatives |
US6277983B1 (en) | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
DK1319008T3 (da) | 2000-09-19 | 2009-02-09 | Wyeth Corp | Vandoplöselige rapamycinestere |
ATE385795T1 (de) | 2002-07-30 | 2008-03-15 | Wyeth Corp | Parenterale formulierungen mit einem rapamycin hydroxyester |
DE602004007145T2 (de) | 2003-08-07 | 2008-02-28 | Wyeth | Regioselektive synthese von cci-779 |
KR20060090803A (ko) | 2003-09-03 | 2006-08-16 | 와이어쓰 | 3-하이드록시-2-(하이드록시메틸)-2-메틸프로피온산을 갖는무정형 라파마이신 42-에스테르 및 이를 함유하는약제학적 조성물 |
RU2006122517A (ru) | 2004-01-08 | 2008-02-20 | Вайет (Us) | Фармацевтический состав для прямого прессования, предназначенный для перорального введения cci-779 |
-
2005
- 2005-04-12 SG SG200902515-6A patent/SG152234A1/en unknown
- 2005-04-12 AU AU2005238431A patent/AU2005238431A1/en not_active Abandoned
- 2005-04-12 US US11/103,799 patent/US7268144B2/en not_active Expired - Fee Related
- 2005-04-12 JP JP2007508442A patent/JP4224115B2/ja not_active Expired - Fee Related
- 2005-04-12 WO PCT/US2005/012266 patent/WO2005105811A1/en active Application Filing
- 2005-04-12 MX MXPA06011881A patent/MXPA06011881A/es active IP Right Grant
- 2005-04-12 CA CA002562952A patent/CA2562952A1/en not_active Abandoned
- 2005-04-12 EP EP05733853A patent/EP1737869A1/en not_active Withdrawn
- 2005-04-12 CN CNA2005800112769A patent/CN1942476A/zh active Pending
- 2005-04-12 BR BRPI0509852-1A patent/BRPI0509852A/pt not_active IP Right Cessation
- 2005-04-12 KR KR1020067021378A patent/KR20070015544A/ko not_active Application Discontinuation
- 2005-04-12 RU RU2006134014/04A patent/RU2387657C2/ru not_active IP Right Cessation
- 2005-04-13 PA PA20058629901A patent/PA8629901A1/es unknown
- 2005-04-13 AR ARP050101447A patent/AR049019A1/es unknown
- 2005-04-13 GT GT200500085A patent/GT200500085A/es unknown
- 2005-04-13 TW TW094111640A patent/TW200536542A/zh unknown
- 2005-04-13 PE PE2005000409A patent/PE20060253A1/es not_active Application Discontinuation
- 2005-12-04 UA UAA200610949A patent/UA87492C2/ru unknown
-
2006
- 2006-09-21 CR CR8646A patent/CR8646A/es not_active Application Discontinuation
- 2006-09-26 IL IL178315A patent/IL178315A0/en unknown
- 2006-10-16 EC EC2006006927A patent/ECSP066927A/es unknown
- 2006-11-03 NO NO20065090A patent/NO20065090L/no not_active Application Discontinuation
-
2008
- 2008-02-19 CL CL200800507A patent/CL2008000507A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2008000507A1 (es) | 2008-07-04 |
UA87492C2 (en) | 2009-07-27 |
CN1942476A (zh) | 2007-04-04 |
RU2387657C2 (ru) | 2010-04-27 |
CA2562952A1 (en) | 2005-11-10 |
PA8629901A1 (es) | 2006-06-02 |
PE20060253A1 (es) | 2006-03-30 |
AR049019A1 (es) | 2006-06-21 |
US7268144B2 (en) | 2007-09-11 |
KR20070015544A (ko) | 2007-02-05 |
BRPI0509852A (pt) | 2007-10-23 |
GT200500085A (es) | 2005-11-03 |
JP2007532134A (ja) | 2007-11-15 |
WO2005105811A1 (en) | 2005-11-10 |
EP1737869A1 (en) | 2007-01-03 |
TW200536542A (en) | 2005-11-16 |
JP4224115B2 (ja) | 2009-02-12 |
AU2005238431A1 (en) | 2005-11-10 |
ECSP066927A (es) | 2006-12-20 |
CR8646A (es) | 2007-08-28 |
IL178315A0 (en) | 2007-02-11 |
NO20065090L (no) | 2006-11-13 |
US20050234234A1 (en) | 2005-10-20 |
RU2006134014A (ru) | 2008-05-20 |
MXPA06011881A (es) | 2006-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG152234A1 (en) | Regiospecific synthesis of rapamycin 42-ester derivatives | |
AU2003241651A1 (en) | Organic el display and method for producing the same | |
IL174793A (en) | Method for producing hydrocarbons and oxygen-containing compounds from biomass | |
MX2007002000A (es) | Metodos y aparatos para portador de boquilla con ajuste de cuña atrapada. | |
TW200615330A (en) | A thermally stabilized polycarbonate composition | |
NO20021361L (no) | Fremgangsmåte for rask og omfattende formasjonsevaluering | |
ZA200800134B (en) | Apparatus and process for the pyrolysis of agricultural biomass | |
AU2003239999A1 (en) | Organic cetane improver | |
Ancheeva et al. | Expanding the metabolic profile of the fungus Chaetomium sp. through co‐culture with autoclaved Pseudomonas aeruginosa | |
GB0813235D0 (en) | Mountings | |
EP1724272A4 (en) | POLYCYCLIC ORGANIC SUBSTANCE WITH FUSED RING CONTAINING CHALCOGENURE AND PROCESS FOR PRODUCING THE SAME | |
EP2016159B8 (de) | Biomassevergaser und verfahren zur allothermen vergasung von biomasse | |
AU2003217480A1 (en) | Organic thin-film device and its production method | |
AU2003250263A1 (en) | Method for the gasification of biomass and corresponding plant | |
AU2003237760A1 (en) | Method and apparatus for production of biogas from an organic material | |
PL1692256T3 (pl) | Fermentor wielkowymiarowy do wytwarzania biogazu z biomasy | |
WO2008070425A3 (en) | Packaged wrinkle-filling grafts and method for cosmetically reducing the appearance of wrinkles | |
WO2008001315A3 (en) | Component supplied with an analog value | |
AU2003269819A1 (en) | Method for destruction of organic compounds by co-oxidation with activated carbon | |
AU2003215216A1 (en) | Methods for searching polynucleotide probe targets in databases | |
EP1876306A3 (en) | Public sanitary facility with lowerable urinal wall | |
WO2004015074A3 (en) | A process for immobilizing an enzyme | |
AU2003203063A1 (en) | Method and installation for gasifying combustible materials | |
WO2005054211A8 (en) | A method of purification of lorazepam | |
AU2003246362A1 (en) | Method for producing s-adenosyl-l-methionine by fermenting genetically modified microorganisms |